Agilon Health, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-404.00
-248.00
-194.00
-90.00
-404.00
-62.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
189.00
130.00
-10.00
-59.00
-55.00
6.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-105.00
-57.00
-156.00
-130.00
-148.00
-53.00
Cash Flow from Investing Activities
88.00
139.00
-44.00
-444.00
-90.00
22.00
Cash Flow from Financing Activities
-2.00
-2.00
-193.00
28.00
1,154.00
24.00
Net Cash Inflow / Outflow
-20.00
79.00
-393.00
-547.00
915.00
-6.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Agilon Health, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-404.096
1346.823
-1,750.00
-130.00%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
189.469
-263.241
452.00
171.98%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-105.763
1888.04
-1,993.00
-105.60%
Cash Flow from Investing Activities
88.61
-671.615
759.00
113.19%
Cash Flow from Financing Activities
-2.994
-1359.654
1,357.00
99.78%
Net Cash Inflow / Outflow
-20.147
-122.078
102.00
83.50%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
21.151
-21.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -83.05% vs 63.01% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-105.76
-57.78
-83.05%






